Martha E. Vincent
Martha Vincent is Vice President of Clinical Research and Development, Agensys, Inc. Martha joined Agensys in 2004 as its first member of the Development organization responsible for nonclinical and early development. Her development responsibilities result in the filing of product INDs with the FDA and testing products in FIM (First in Man) protocols through Phase II proof of concept studies. Her functional responsibilities include supervising the supportive departments of toxicology, pharmacokinetics, clinical operations, safety, clinical data management, clinical quality assurance, and biostatistics.
Martha joined Agensys from Amgen where she served in a number of capacities over a period of 17 years. At Amgen, she served as Vice President, Medical Affairs. She led the design and execution of all non-registrational clinical programs for marketed products in multiple therapeutic areas including, nephrology, oncology, and inflammation. Her Medical Affairs responsibilities encompassed Medical Operations, Pharmacoeconomics, Biostatistics and Data Warehousing, Safety, Medical Writing, Outsourcing and Contract Management. She also served as Vice President, Clinical Development, and in that capacity her responsibilities included worldwide oversight of the Clinical Development Department where she led the design and execution of all registrational clinical programs, generated registrational data from Phase 1 - 3, and was responsible for the approvals of Neupogen, Infergen and Stemgen. Martha led all the development teams that conducted international registrations and filed multiple simultaneous submissions for Amgen's products.
Prior to Amgen Dr. Vincent served as Director, Cardiovascular Clinical Research for Schering Corporation. She has also held positions with AYERST, a division of American Home Products and with New Jersey Medical School, Department of Pharmacology. She serves on several non-profit boards and is a member of numerous professional groups. She is a Fellow of the American College of Clinical Pharmacology and was the recipient of multiple awards for education and leadership including: Distinguished Alumnus Award, New Jersey Medical School, Leadership America-Women in Action Award, Israel Cancer Research-Women of Achievement and Leadership America Award, Anti-Defamation League-Deborah Award and Citation of Merit Award, Iowa State University. Martha recently received the HBA (Healthcare Business Women's Association) award for Woman of the Year, 2012 and was featured as Women Making a Difference Award in the Los Angeles Business Journal, 2012.
Dr. Vincent received a BSc in Biology and Education from Iowa State University, and a PhD in Pharmacology from the University of Medicine and Dentistry of New Jersey. She did her post-doctoral work at Thomas Jefferson University, Philadelphia. She has authored more than 40 scientific publications in major journals.